AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Market cap $5.5B
Insiders sold $7.2M net in the last 90 days ·3 sellers, 0 buyers· latest Form 4 filed Aug 14, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.8M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Sep 14, 2026
Kiely John
Amneal Pharmaceuticals, Inc. (AMRX) has 28 SEC Form 4 filings (78 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Sep 14, 2026.
Inside the rolling window, 5 insiders at Amneal Pharmaceuticals, Inc. reported no open-market purchases and 7 open-market sales totaling $9.8M. Insiders have net sold $7.7M over the trailing 6 months. The most recent open-market filing is a sale of 50,000 shares by Director Kiely John, dated Aug 13, 2026, worth $882K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Chirag K. Patel
- Employees:8,500
- HQ:Bridgewater, NJ, US
- IPO:2018-05-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
Kiely JohnFirst filing | Director | Sale | 50,000 | $882K | Aug 14 | -5.1% | SEC ↗ |
Daly Jason B.First filing | EVP, Chief Legal Officer | Sale | 6,613 | $117K | Aug 13 | -0.3% | SEC ↗ |
Daly Jason B.First filing | EVP, Chief Legal Officer | Sale | 210,000 | $3.7M | Aug 13 | -0.3% | SEC ↗ |
Shah NikitaFirst in 9 months | Executive Vice President | Sale | 146,403 | $2.6M | Aug 13 | -0.3% | SEC ↗ |
Autor Deborah M.First in 5 months | Director | Sale | 34,819 | $451K | May 12 | +36.7% | SEC ↗ |
Nark Ted CFirst filing | Director | Sale | 50,000 | $586K | Nov 19 | +49.5% | SEC ↗ |
Shah NikitaFirst filing | Executive Vice President | Sale | 131,856 | $1.6M | Nov 14 | +47.9% | SEC ↗ |
Earnings: last 7 quarters
Congress trading AMRX 1 all-time
- DRep. Josh S. GottheimerOther$1,001 - $15,0002019-05-24
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does AMRX have?
Amneal Pharmaceuticals, Inc. (AMRX) has 28 SEC Form 4 filings (78 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Sep 14, 2026.
When was the most recent SEC Form 4 filing for AMRX?
The most recent Form 4 filing for AMRX on Tracefour is dated Sep 14, 2026.
What is the net insider flow at AMRX over the last 6 months?
Over the trailing 180 days, insiders at AMRX have net sold $7.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AMRX in the current window?
Inside the rolling window, insiders at AMRX bought $0 and sold $9.8M based on SEC Form 4 filings.
Can I get alerts for AMRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Amneal Pharmaceuticals, Inc. (AMRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Amneal Pharmaceuticals, Inc. is in the Healthcare sector.